Lilly/Verge Pact Shows Resistance To Biopharma AI Is Futile

 
• By Alaric DeArment
  
AI hand reaches
Eli Lilly and Verge announced a drug discovery and development deal centered on amyotrophic lateral sclerosis • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business